1. Home
  2. MIRM vs SA Comparison

MIRM vs SA Comparison

Compare MIRM & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$100.65

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Logo Seabridge Gold Inc. (Canada)

SA

Seabridge Gold Inc. (Canada)

HOLD

Current Price

$34.17

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIRM
SA
Founded
2018
1979
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.7B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
MIRM
SA
Price
$100.65
$34.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
1
Target Price
$102.64
$65.00
AVG Volume (30 Days)
733.0K
1.4M
Earning Date
02-26-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$471,794,000.00
N/A
Revenue This Year
$55.91
N/A
Revenue Next Year
$23.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
53.66
N/A
52 Week Low
$36.88
$9.40
52 Week High
$105.74
$37.99

Technical Indicators

Market Signals
Indicator
MIRM
SA
Relative Strength Index (RSI) 64.68 58.80
Support Level $97.49 $27.51
Resistance Level $105.74 $30.75
Average True Range (ATR) 3.71 2.33
MACD -0.79 0.06
Stochastic Oscillator 62.01 64.65

Price Performance

Historical Comparison
MIRM
SA

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About SA Seabridge Gold Inc. (Canada)

Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.

Share on Social Networks: